FDA Investigator Mohsen Rajabi Abhari, FDA
Mohsen Rajabi Abhari, FDA has inspections in 9 countries as of 21 Sep 2023. Mohsen Rajabi Abhari, FDA has collaborated with a combined 4999 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Canada,
India,
Netherlands,
Israel,
Germany,
Spain,
Switzerland
Co-Investigator(s):
Ademola O Daramola,
Alan P Kurtzberg,
Alanna Lmussawwir Bias,
Alexander M Kay,
Alia Legaux,
Allan P Kurtzberg,
Allen F Hall,
Amalia C Himaya,
Amalia Himaya,
Amanda E Lewin, PhD,
Anders W Evenson,
Andrace Lde Yampert,
Andrea A Branche,
Anita Narula, PhD,
Anita R Michael,
Anthony E Keller, RPh,
Arindam Dasgupta, PhD,
Barbara Janine Breithaupt,
Barry Cherney, PhD,
Benton M Ketron,
Bichsa T Nguyen,
Bichsa T Tran,
Bo Chi, PhD,
Bonita S Chester,
Brandy D Brown,
Brett R Havranek,
Brien C Fox,
Burnell M Henry,
Byungja E Marciante,
Cara M Minelli,
Carl J Montgomery,
Carla J Lundi,
Caryn M Mcnab,
CDR Rochelle B Young, RPh, MSA,
Chaoying C Ma,
Charles R Bonapace, PhD,
Charles R Cote, RIC,
Chase Bourke, PhD,
Cheron M Portee,
Chris A Sack,
Christina V Santos,
Comyar Shoghi,
Corey K Reno,
Courtney N Long,
Craig A Garmendia,
Cynthia L Evitt,
Cynthia White,
Daniel J Lahar,
Daniel J Roberts,
Daniel L Aisen,
Daniel W Cline,
David M Mcnew,
David R Heiar,
Davinna Ligons, PhD,
Dawn C Olenjack,
Dawn L Wydner,
Denise L Burosh,
Denise M Visco, Investigator,
Diane Cvan Leeuwen,
Dipesh K Shah,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Douglas A Campbell,
Dr. Abhijit Raha, PhD,
Dr. Carmelo Rosa,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Edward D Mcdonald,
Edwin Melendez,
Eileen A Liu,
Eric C Nielsen,
Eric M Mueller, PharmD,
Farhana Khan,
Felix Maldonado,
Frances Namuswe, PhD,
Gabriel Davila,
Gajendiran Mahadevan, PhD,
Gary T Greco,
Gavin T Cua,
Gene D Arcy,
George C Amedro,
George Ivan Wey,
Gloria E Parra,
Gopa Biswan,
Gulshan R Anand,
Haley H Seymour,
Haley Seymour,
Hanna L Potter,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Hector J Colon Torres,
Himanshu Gupta, PhD,
Iram R Hassan, PhD,
Iris C Macinnes,
Ismael Olvera, IV,
Jacob G Lutz,
Jacob W Reynolds,
Jacqueline A Shaughnessy, PhD,
James M Kewley,
James R Fleckenstein,
Jane E Nelson,
Janete F Guardia,
Jasjeet K Sekhon,
Jean M Kelahan,
Jee Chung, PhD,
Jefferey A Hangartner,
Jeffery A Hangartner,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Jessica E Hensley,
Jessica L Peterson,
Joanne M Schlossin,
Joel D Martinez,
Joel Welch, PhD,
John A Iwen,
John A Kadavil, PhD,
John R Myung,
John S Hartford,
Jonathan R Campos,
Jonee J Mearns,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Joseph L Despins, PhD,
Joseph R Lambert,
Jun Park, PhD,
Junho Pak,
Justin A Boyd,
Jyoti B Patel, PhD,
Ka L Wong,
Kara A Scheibner, PhD,
Karen L Kosar,
Karen M Cooper,
Kathleen R Jones, PhD,
Kathryn A Krentz,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kenneth H Williams,
Kevin A Gonzalez,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberly A Benson,
Kirtida Patel,
Lakecha N Lewis,
Lata C Mathew, PhD,
Latonya M Mitchell,
Laura Fontan, MS,
Laverne Puckett,
LCDR Chad N Thompson,
Leonard H Lavi,
Lequita M Mayhew,
Li Hongpaul Yeh, PhD,
Linda M Cheny,
Linda R Kuchenthal,
Linda S Leja,
Linda Thai,
Lori A Gioia,
Lori J Silverstein,
M Patriciaurphy Murphy,
Maan S Abduldayem,
Makini Cobourne Duval, PhD,
Marc R Dickens,
Marcia Britt Williams,
Marcus F Yambot,
Margaret E Sarles,
Margaret M Annes,
Margaret M Sands,
Martin K You,
Matthew B Casale,
Matthew C Watson,
Maxyne T Lam,
Melkamu Getie Kebtie, PhD,
Michael A Taylor,
Michael F Skelly, PhD,
Michael G Sinkevich,
Michael R Goga,
Michael Serrano,
Michelle A Marsh,
Mihaly S Ligmond,
Mike M Rashti,
Mra M Barbosar,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Nancy L Rolli,
Nathan R Moon,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas C Mendiola,
Nicholas Obiri, PhD,
Nicholas Z Lu,
Nicola M Fenty Stewart,
Nicole M Bell,
Nilufer M Tampal, PhD,
Nina Yang,
Niraj R Mehta, PhD,
Omotunde O Osunsanmi,
Pamela L Vega,
Pankaj H Amin,
Parul M Patel,
Patrick L Wisor,
Paul A Bonneau,
Paul L Bellamy,
Paula J Bretz,
Peter R Lenahan,
Peter S Diak,
Raymond T Oji,
Rebecca Rodriguez,
Richard W Berning,
Richmond K Yip,
Robert C Steyert,
Robert D Tollefsen,
Robert Darius,
Robert J Doyle,
Rodney D Combs,
Roger F Zabinski,
Ronald L Koller,
Ronald R Ruff,
Ronda Lebland,
Ruben C Ayala, PharmD,
Russ E Davis,
Saied A Asbagh,
Sam H Haidar, PhD,
Samantha J Pinizzotto, D V M,
Sandra A Hughes,
Sandra S Saniga,
Sarah Arden,
Sarah E Rhoades,
Scott B Laudenberg,
Scott B Laufenberg,
Scott R Nichols, PhD,
Sherri N Rohlf, MD,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sonia R Peterson,
Sripal R Mada, PhD,
Stacey S Degarmo,
Stanley Au,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven Fong, MS, PhD,
Steven M Weinman,
Steven P Donald,
Sunitha K Rajaram, PhD,
Susan D Yuscius,
Susanna E Ford, Analyst,
Susanne M Richardson, MSc RAC ELS,
Taichun Qin, PhD,
Tawny L Colling,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thea C Grome,
Theressa B Smith,
Thomas W Nojek,
Timothy C Grome,
Timothy T Kapsala,
Torrance J Slayton,
Tracey L Harris,
Traci C Kelm,
Uttaniti Limchumroon (Tom),
Vickie J Kanion,
Vlada Matusovsky,
Wayne T Smith,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yanming An, PhD,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Yumi J Hiramine,
Yvonne C Wilkes,
Zachary A Bogorad
Mohsen Rajabi Abhari, FDA's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2018 | FDA 483 Response | PPD Development, L.P. - Form 483R, 2018-06-05 |
April, 2019 | EIR | Ppd Development, L.P. - EIR, 2019-04-26 |
December, 2016 | FDA 483 | QPS, LLC - Form 483, 2016-12-16 |
December, 2017 | FDA 483 | Celerion, Inc - Form 483, 2017-12-08 |
November, 2017 | FDA 483 | Intertek USA, Inc. - Form 483, 2017-11-09 |
February, 2017 | FDA 483 | Amgen, Inc - Form 483, 2017-02-17 |
November, 2017 | EIR | Intertek USA, Inc. - EIR, 2017-11-09 |
May, 2018 | FDA 483 | PPD Development, L.P. - Form 483, 2018-05-18 |
March, 2017 | FDA 483 | ICON Development Solutions, LLC - Form 483, 2017-03-10 |
August, 2015 | FDA 483 | Eurofins Pharma Bioanalytics Services US Inc. - Form 483, 2015-08-21 |
May, 2018 | EIR | PPD Development, L.P. - EIR, 2018-05-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more